Working toward international consensus defining pediatric "refractory ITP".
作者信息
O'Farrell Candelaria, Bell Grimes Amanda, Nakano Taizo A, Klaassen Robert J, Lambert Michele P, Neunert Cindy, Rothman Jennifer A, Shimano Kristin A, Grace Rachael F
机构信息
Department of Pediatrics, Texas Children's Hematology Center, Baylor College of Medicine, Houston, TX.
Department of Pediatrics, Center for Cancer and Blood Disorders, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
出版信息
Blood Adv. 2025 Mar 11;9(5):1244-1245. doi: 10.1182/bloodadvances.2024015219.
Abstract
摘要
相似文献
1
Working toward international consensus defining pediatric "refractory ITP".致力于达成关于定义儿童“难治性免疫性血小板减少症”的国际共识。
Blood Adv. 2025 Mar 11;9(5):1244-1245. doi: 10.1182/bloodadvances.2024015219.
2
What is in a name: defining pediatric refractory ITP.名字的含义：定义儿童难治性 ITP。
Blood Adv. 2024 Oct 8;8(19):5112-5117. doi: 10.1182/bloodadvances.2024012707.
3
Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population.2009 年国际免疫性血小板减少症共识术语和标准在临床儿科人群中的适用性。
Pediatr Blood Cancer. 2012 Feb;58(2):216-20. doi: 10.1002/pbc.23112. Epub 2011 Jun 14.
4
Dapsone: An Old but Effective Therapy in Pediatric Refractory Immune Thrombocytopenia.氨苯砜：治疗儿童难治性免疫性血小板减少症的一种古老但有效的疗法。
Indian J Hematol Blood Transfus. 2020 Oct;36(4):690-694. doi: 10.1007/s12288-020-01286-9. Epub 2020 May 7.
5
Pediatric refractory immune thrombocytopenia: A systematic review.儿童难治性免疫性血小板减少症：系统评价。
Pediatr Blood Cancer. 2023 Mar;70(3):e30173. doi: 10.1002/pbc.30173. Epub 2022 Dec 29.
6
Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus.西班牙新的 ITP 治疗药物上市背景下的真实临床实践。基于德尔菲法的西班牙专家小组共识。
Platelets. 2024 Dec;35(1):2336104. doi: 10.1080/09537104.2024.2336104. Epub 2024 May 14.
7
Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.儿童难治性特发性免疫性血小板减少性紫癜：当前及未来的治疗选择
Paediatr Drugs. 2003;5(12):795-801. doi: 10.2165/00148581-200305120-00003.
8
Chronic refractory immune thrombocytopenia in adolescents and young adults.青少年和年轻成人的慢性难治性免疫性血小板减少症。
Br J Haematol. 2023 Oct;203(1):36-42. doi: 10.1111/bjh.19081.
9
Eltrombopag in pediatric chronic and refractory ITP: data from a retrospective multicenter study from Lebanon.芦可替尼在儿科慢性和难治性 ITP 中的应用：来自黎巴嫩一项回顾性多中心研究的数据。
Ann Hematol. 2022 May;101(5):991-997. doi: 10.1007/s00277-022-04804-z. Epub 2022 Mar 12.
10
[Individualizing treatment of refractory and relapsed ITP in adults and its development of study].[成人难治性和复发性免疫性血小板减少症的个体化治疗及其研究进展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1609-15.
引用本文的文献
1
Plasma Exosomes Derived from Patients with Primary Immune Thrombocytopenia Attenuate TBX21 Regulatory T Cell-Mediated Immune Suppression via MiR-363-3p.原发性免疫性血小板减少症患者来源的血浆外泌体通过MiR-363-3p减轻TBX21调节性T细胞介导的免疫抑制。
Inflammation. 2025 Mar 4. doi: 10.1007/s10753-025-02275-8.
本文引用的文献
1
Pediatric refractory ITP, a definition to be defined.儿童难治性免疫性血小板减少症，有待定义的一种病症。
Blood Adv. 2025 Mar 11;9(5):1242-1243. doi: 10.1182/bloodadvances.2024015195.
2
What is in a name: defining pediatric refractory ITP.名字的含义：定义儿童难治性 ITP。
Blood Adv. 2024 Oct 8;8(19):5112-5117. doi: 10.1182/bloodadvances.2024012707.
3
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology.儿童急性免疫性血小板减少症的管理建议。来自意大利儿科血液学和肿瘤学会的共识会议。
Blood Transfus. 2024 May;22(3):253-265. doi: 10.2450/BloodTransfus.501. Epub 2024 Jan 29.
Zotero 插件